Early Detection of Treatment Response in Lung Cancer Using Delta-Radiomics Features
The study conducted by Heidelberg University Hospital investigates the use of diffusion-weighted MRI (DWI) to predict early treatment outcomes in…
Heidelberg University Hospital: Delta-Radiomics Features from ADC Maps as Early Predictors of Treatment Success in Lung Cancer Therapy
In this prospective study conducted by Heidelberg University Hospital, researchers investigated whether changes in radiomic features from…
ICIS 2024
09/27
to
09/29/2024
SINGAPORE
ICIS Annual Teaching Course, Joint Meeting with SGCR-WIRES
ESOI Touchdown 2024
09/19
to
09/21/2024
Valencia, Spain
Touchdown Valencia 2024
ESMO 2024
09/13
to
09/17/2024
BARCELONA, SPAIN
ESMO Congress 2024
Healthcare on FHIR: Igniting the Potential of Interoperability
Interoperability plays a crucial role in healthcare: it enables seamless communication of patient information across different systems, leads to…
Optimizing Glioblastoma Imaging: Enhancing MRI Efficiency and Quality with Deep Learning
This study investigates the use of deep learning (DL) to optimize MRI protocols for glioblastoma patients, aiming to reduce scan time and improve…
University Hospital Tübingen: Advancing MRI Efficiency in Glioblastoma Care with Deep Learning
This study explores the use of deep learning (DL) to optimize MRI protocols for glioblastoma patients. Glioblastomas, known for being the most…
Insights into the BORN Project: Development and Successes with Dr. Maurice Heimer
The BORN-project of the Bavarian Center for Cancer Research (BZKF) is making swift progress in its second funding phase. A key aspect of the project…
About Cookies
This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.